Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Typhoid Fever | 22 | 2016 | 197 | 1.730 |
Why?
|
Pneumonectomy | 24 | 2015 | 1094 | 1.240 |
Why?
|
Tracheal Stenosis | 13 | 2009 | 226 | 1.230 |
Why?
|
Lung Neoplasms | 98 | 2015 | 13102 | 1.190 |
Why?
|
Salmonella typhi | 13 | 2016 | 201 | 1.170 |
Why?
|
Lung Transplantation | 30 | 2015 | 1153 | 1.100 |
Why?
|
Polymorphism, Genetic | 42 | 2012 | 4328 | 1.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 42 | 2015 | 5221 | 0.970 |
Why?
|
Esophageal Neoplasms | 23 | 2016 | 1583 | 0.920 |
Why?
|
Tracheal Neoplasms | 9 | 2010 | 124 | 0.740 |
Why?
|
Multilocus Sequence Typing | 5 | 2014 | 100 | 0.670 |
Why?
|
Trachea | 14 | 2012 | 1076 | 0.630 |
Why?
|
Bronchial Neoplasms | 4 | 2010 | 112 | 0.590 |
Why?
|
Esophagectomy | 10 | 2015 | 447 | 0.580 |
Why?
|
Laryngostenosis | 5 | 2015 | 161 | 0.550 |
Why?
|
Airway Obstruction | 6 | 2010 | 664 | 0.550 |
Why?
|
Thymoma | 6 | 2008 | 186 | 0.530 |
Why?
|
Escherichia coli Infections | 4 | 2017 | 532 | 0.530 |
Why?
|
Escherichia coli | 5 | 2017 | 4217 | 0.510 |
Why?
|
Smoking | 44 | 2012 | 8987 | 0.510 |
Why?
|
Adenocarcinoma | 35 | 2015 | 6364 | 0.500 |
Why?
|
Thymus Neoplasms | 6 | 2008 | 268 | 0.500 |
Why?
|
Bronchoscopy | 9 | 2021 | 862 | 0.460 |
Why?
|
Intubation, Intratracheal | 8 | 2009 | 1364 | 0.440 |
Why?
|
Anastomosis, Surgical | 15 | 2015 | 987 | 0.410 |
Why?
|
Thoracoscopy | 5 | 2006 | 178 | 0.400 |
Why?
|
Catheterization | 4 | 2011 | 1470 | 0.370 |
Why?
|
Feces | 5 | 2013 | 1401 | 0.360 |
Why?
|
Bronchiolitis Obliterans | 7 | 2006 | 192 | 0.360 |
Why?
|
Culture Media | 3 | 2008 | 908 | 0.360 |
Why?
|
Pulmonary Surgical Procedures | 1 | 2010 | 29 | 0.360 |
Why?
|
Laryngeal Neoplasms | 6 | 2012 | 512 | 0.360 |
Why?
|
Carcinoid Tumor | 2 | 2010 | 235 | 0.350 |
Why?
|
Idiopathic Pulmonary Fibrosis | 3 | 2021 | 451 | 0.350 |
Why?
|
Salmonella Infections | 5 | 2014 | 173 | 0.350 |
Why?
|
Thoracotomy | 9 | 2009 | 363 | 0.340 |
Why?
|
DNA Adducts | 6 | 2012 | 93 | 0.340 |
Why?
|
Carcinoma, Squamous Cell | 24 | 2015 | 4034 | 0.330 |
Why?
|
Polymorphism, Single Nucleotide | 12 | 2016 | 15519 | 0.330 |
Why?
|
Bronchial Diseases | 5 | 2005 | 151 | 0.330 |
Why?
|
Intestinal Diseases | 1 | 2013 | 530 | 0.320 |
Why?
|
Middle Aged | 182 | 2021 | 213383 | 0.320 |
Why?
|
Genes, p53 | 10 | 2004 | 755 | 0.320 |
Why?
|
Genotype | 40 | 2016 | 12951 | 0.310 |
Why?
|
Ofloxacin | 7 | 2006 | 65 | 0.310 |
Why?
|
Aged | 154 | 2021 | 163280 | 0.310 |
Why?
|
Polymerase Chain Reaction | 23 | 2016 | 6171 | 0.300 |
Why?
|
Lung Diseases | 11 | 2015 | 1886 | 0.300 |
Why?
|
Postoperative Complications | 34 | 2015 | 15295 | 0.300 |
Why?
|
Salmonella enterica | 4 | 2014 | 75 | 0.300 |
Why?
|
Tracheal Diseases | 4 | 2005 | 113 | 0.290 |
Why?
|
Male | 206 | 2021 | 350118 | 0.280 |
Why?
|
Lung | 24 | 2015 | 9856 | 0.270 |
Why?
|
Esophageal Diseases | 4 | 2008 | 166 | 0.270 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 4 | 2015 | 312 | 0.270 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2011 | 740 | 0.270 |
Why?
|
Adult | 145 | 2017 | 214055 | 0.270 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 4 | 2009 | 380 | 0.270 |
Why?
|
Polysaccharides, Bacterial | 1 | 2008 | 578 | 0.260 |
Why?
|
DNA Repair | 10 | 2011 | 2046 | 0.260 |
Why?
|
Infarction | 1 | 2006 | 244 | 0.260 |
Why?
|
Female | 203 | 2021 | 380194 | 0.260 |
Why?
|
Vietnam | 9 | 2014 | 408 | 0.260 |
Why?
|
Endonucleases | 6 | 2010 | 380 | 0.250 |
Why?
|
Glutathione Transferase | 7 | 2003 | 595 | 0.250 |
Why?
|
Bone Marrow | 2 | 2008 | 2948 | 0.250 |
Why?
|
Humans | 260 | 2021 | 744343 | 0.250 |
Why?
|
Case-Control Studies | 41 | 2014 | 21746 | 0.250 |
Why?
|
Transplantation, Homologous | 14 | 2015 | 4776 | 0.240 |
Why?
|
Phylogeny | 2 | 2014 | 2803 | 0.240 |
Why?
|
Mediastinal Neoplasms | 3 | 2009 | 423 | 0.240 |
Why?
|
Antibodies, Bacterial | 2 | 2008 | 1470 | 0.240 |
Why?
|
Salmonella typhimurium | 3 | 2014 | 351 | 0.240 |
Why?
|
Pleural Diseases | 4 | 2001 | 139 | 0.240 |
Why?
|
Neoadjuvant Therapy | 8 | 2016 | 2728 | 0.230 |
Why?
|
Stents | 3 | 2010 | 3280 | 0.230 |
Why?
|
Immune Tolerance | 6 | 2015 | 2258 | 0.220 |
Why?
|
Clinical Laboratory Techniques | 1 | 2008 | 738 | 0.220 |
Why?
|
Xeroderma Pigmentosum Group D Protein | 7 | 2009 | 105 | 0.220 |
Why?
|
Polymorphism, Restriction Fragment Length | 9 | 2016 | 768 | 0.220 |
Why?
|
Chondrosarcoma | 3 | 2017 | 309 | 0.220 |
Why?
|
Graft Rejection | 14 | 2012 | 4397 | 0.220 |
Why?
|
Bacterial Proteins | 3 | 2010 | 3848 | 0.220 |
Why?
|
Colon | 4 | 2008 | 1772 | 0.220 |
Why?
|
Tissue Adhesives | 2 | 2001 | 179 | 0.210 |
Why?
|
Laryngectomy | 6 | 2012 | 248 | 0.210 |
Why?
|
Muromonab-CD3 | 2 | 1999 | 96 | 0.210 |
Why?
|
Survival Rate | 25 | 2015 | 12788 | 0.210 |
Why?
|
Pneumothorax | 2 | 2006 | 379 | 0.200 |
Why?
|
Brachytherapy | 1 | 2010 | 1248 | 0.200 |
Why?
|
Neoplasm Staging | 29 | 2016 | 11031 | 0.200 |
Why?
|
Salmonella Food Poisoning | 2 | 2011 | 14 | 0.200 |
Why?
|
Bacterial Typing Techniques | 2 | 2016 | 256 | 0.200 |
Why?
|
Asbestos | 8 | 2001 | 251 | 0.200 |
Why?
|
DNA-Binding Proteins | 13 | 2011 | 9648 | 0.200 |
Why?
|
Histocompatibility Antigens Class II | 5 | 2006 | 1475 | 0.200 |
Why?
|
Colony Count, Microbial | 2 | 2001 | 331 | 0.200 |
Why?
|
Acrylates | 1 | 2001 | 89 | 0.200 |
Why?
|
Neoplasm Recurrence, Local | 15 | 2015 | 9239 | 0.200 |
Why?
|
Major Histocompatibility Complex | 6 | 2015 | 936 | 0.190 |
Why?
|
Aged, 80 and over | 61 | 2015 | 57776 | 0.190 |
Why?
|
Staphylococcus aureus | 1 | 2009 | 1451 | 0.190 |
Why?
|
Bacteriological Techniques | 3 | 2012 | 277 | 0.190 |
Why?
|
Treatment Outcome | 52 | 2017 | 63114 | 0.190 |
Why?
|
Adolescent | 58 | 2015 | 85781 | 0.190 |
Why?
|
Pulmonary Circulation | 5 | 2006 | 739 | 0.190 |
Why?
|
Bronchi | 6 | 2018 | 840 | 0.180 |
Why?
|
Esophagus | 5 | 2012 | 1019 | 0.180 |
Why?
|
Salmonella Phages | 2 | 2011 | 11 | 0.180 |
Why?
|
Cisplatin | 11 | 2016 | 1662 | 0.170 |
Why?
|
Tomography, Optical Coherence | 3 | 2021 | 2657 | 0.170 |
Why?
|
Tracheostomy | 3 | 1995 | 401 | 0.170 |
Why?
|
Gastric Outlet Obstruction | 2 | 2011 | 56 | 0.170 |
Why?
|
Pylorus | 2 | 2011 | 86 | 0.170 |
Why?
|
Histocompatibility Antigens Class I | 5 | 2008 | 1366 | 0.160 |
Why?
|
Carcinoma, Adenoid Cystic | 4 | 2010 | 252 | 0.160 |
Why?
|
Swine, Miniature | 11 | 2012 | 961 | 0.160 |
Why?
|
Anti-Bacterial Agents | 9 | 2017 | 7181 | 0.160 |
Why?
|
Genetic Predisposition to Disease | 18 | 2012 | 17446 | 0.160 |
Why?
|
Graft Survival | 8 | 2009 | 3737 | 0.160 |
Why?
|
Drug Resistance, Bacterial | 3 | 2017 | 1035 | 0.160 |
Why?
|
Helicobacter Infections | 2 | 2014 | 386 | 0.160 |
Why?
|
Respiratory Tract Diseases | 3 | 2001 | 722 | 0.150 |
Why?
|
Diaphragm | 6 | 2009 | 349 | 0.150 |
Why?
|
Fistula | 2 | 1996 | 220 | 0.150 |
Why?
|
Bronchial Fistula | 4 | 2002 | 85 | 0.150 |
Why?
|
Matrix Metalloproteinase 1 | 3 | 2008 | 141 | 0.150 |
Why?
|
Neoplasm Invasiveness | 10 | 2015 | 3616 | 0.150 |
Why?
|
Vascular Endothelial Growth Factor A | 4 | 2009 | 3508 | 0.150 |
Why?
|
Gastroesophageal Reflux | 5 | 2011 | 782 | 0.150 |
Why?
|
DNA Helicases | 4 | 2004 | 859 | 0.140 |
Why?
|
Superoxide Dismutase | 3 | 2004 | 597 | 0.140 |
Why?
|
Gene Dosage | 2 | 2011 | 1252 | 0.140 |
Why?
|
Carcinoma, Bronchogenic | 4 | 2001 | 87 | 0.140 |
Why?
|
Vasoconstriction | 3 | 1994 | 597 | 0.140 |
Why?
|
Virulence | 4 | 2017 | 1333 | 0.140 |
Why?
|
Empyema, Pleural | 1 | 1996 | 62 | 0.140 |
Why?
|
Retrospective Studies | 52 | 2017 | 77449 | 0.140 |
Why?
|
Genes, ras | 6 | 2001 | 690 | 0.140 |
Why?
|
Nalidixic Acid | 3 | 2006 | 19 | 0.130 |
Why?
|
Tobacco Smoke Pollution | 3 | 2008 | 816 | 0.130 |
Why?
|
Drug Resistance, Multiple, Bacterial | 5 | 2014 | 567 | 0.130 |
Why?
|
Hydrogels | 1 | 2001 | 724 | 0.130 |
Why?
|
Time Factors | 29 | 2015 | 40075 | 0.130 |
Why?
|
Polyethylene Glycols | 1 | 2001 | 1182 | 0.130 |
Why?
|
Receptors, Calcitriol | 2 | 2008 | 350 | 0.130 |
Why?
|
Child | 38 | 2014 | 77709 | 0.130 |
Why?
|
Reoperation | 10 | 2011 | 4201 | 0.130 |
Why?
|
Swine | 16 | 2012 | 5917 | 0.130 |
Why?
|
Tracheotomy | 3 | 2004 | 166 | 0.130 |
Why?
|
Prognosis | 24 | 2015 | 29063 | 0.130 |
Why?
|
England | 5 | 2014 | 522 | 0.130 |
Why?
|
Tracheoesophageal Fistula | 3 | 2012 | 129 | 0.120 |
Why?
|
Cricoid Cartilage | 2 | 2012 | 72 | 0.120 |
Why?
|
Hemorrhage | 1 | 2006 | 3461 | 0.120 |
Why?
|
Bird Diseases | 1 | 2014 | 19 | 0.120 |
Why?
|
Endothelins | 1 | 1994 | 138 | 0.120 |
Why?
|
Pharmacogenetics | 2 | 2009 | 675 | 0.120 |
Why?
|
DNA Primers | 7 | 2009 | 2892 | 0.120 |
Why?
|
Osteoarthropathy, Secondary Hypertrophic | 1 | 1993 | 13 | 0.120 |
Why?
|
Chickens | 2 | 2013 | 865 | 0.120 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2016 | 320 | 0.120 |
Why?
|
Chordoma | 1 | 2017 | 359 | 0.120 |
Why?
|
Azithromycin | 3 | 2006 | 196 | 0.120 |
Why?
|
Vena Cava, Superior | 2 | 2009 | 193 | 0.120 |
Why?
|
Thoracic Vertebrae | 2 | 2017 | 608 | 0.120 |
Why?
|
Escherichia coli O157 | 1 | 2014 | 54 | 0.120 |
Why?
|
Isoenzymes | 3 | 2003 | 1726 | 0.120 |
Why?
|
Leukocytes, Mononuclear | 3 | 2010 | 1836 | 0.120 |
Why?
|
Carcinogens | 3 | 2010 | 466 | 0.120 |
Why?
|
Follow-Up Studies | 27 | 2014 | 39050 | 0.120 |
Why?
|
Haplotypes | 6 | 2016 | 2779 | 0.120 |
Why?
|
Serotyping | 1 | 2014 | 338 | 0.120 |
Why?
|
Lymphatic Metastasis | 10 | 2015 | 2924 | 0.120 |
Why?
|
Immunosuppressive Agents | 5 | 2006 | 4149 | 0.110 |
Why?
|
Thoracic Surgery | 4 | 1995 | 719 | 0.110 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 2 | 2012 | 284 | 0.110 |
Why?
|
DNA Damage | 5 | 2004 | 2432 | 0.110 |
Why?
|
Pulmonary Aspergillosis | 1 | 2013 | 47 | 0.110 |
Why?
|
Thymectomy | 4 | 2008 | 191 | 0.110 |
Why?
|
Glutathione S-Transferase pi | 4 | 2006 | 97 | 0.110 |
Why?
|
Minisatellite Repeats | 1 | 2014 | 165 | 0.110 |
Why?
|
Logistic Models | 15 | 2013 | 13408 | 0.110 |
Why?
|
Solitary Fibrous Tumor, Pleural | 1 | 2012 | 25 | 0.110 |
Why?
|
Lung Diseases, Obstructive | 3 | 1998 | 316 | 0.110 |
Why?
|
Zoonoses | 1 | 2014 | 185 | 0.110 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2015 | 273 | 0.110 |
Why?
|
Risk Factors | 44 | 2015 | 72290 | 0.110 |
Why?
|
Codon | 6 | 2004 | 611 | 0.110 |
Why?
|
Biopsy | 8 | 2011 | 6756 | 0.110 |
Why?
|
Campylobacter Infections | 1 | 2012 | 32 | 0.110 |
Why?
|
DNA, Bacterial | 4 | 2016 | 1465 | 0.110 |
Why?
|
Disease-Free Survival | 10 | 2016 | 6895 | 0.110 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 11 | 2016 | 11524 | 0.110 |
Why?
|
Surgical Flaps | 6 | 2004 | 1640 | 0.110 |
Why?
|
Cystic Fibrosis | 3 | 2012 | 1177 | 0.110 |
Why?
|
Caliciviridae Infections | 1 | 2012 | 29 | 0.100 |
Why?
|
Survival Analysis | 16 | 2015 | 10252 | 0.100 |
Why?
|
Osteotomy | 1 | 2017 | 822 | 0.100 |
Why?
|
Thymus Gland | 3 | 2003 | 1267 | 0.100 |
Why?
|
Age Factors | 15 | 2013 | 18370 | 0.100 |
Why?
|
beta-Lactamases | 1 | 2013 | 306 | 0.100 |
Why?
|
Radiotherapy, Adjuvant | 6 | 2010 | 1770 | 0.100 |
Why?
|
Virulence Factors | 2 | 2017 | 509 | 0.100 |
Why?
|
Esophageal Stenosis | 3 | 2008 | 195 | 0.100 |
Why?
|
Esophagoscopy | 2 | 2011 | 390 | 0.100 |
Why?
|
Bacteremia | 1 | 1998 | 962 | 0.100 |
Why?
|
Meningocele | 1 | 2011 | 45 | 0.100 |
Why?
|
Combined Modality Therapy | 17 | 2009 | 8642 | 0.100 |
Why?
|
Angiogenic Proteins | 1 | 2011 | 104 | 0.100 |
Why?
|
Fanconi Anemia Complementation Group D2 Protein | 1 | 2011 | 148 | 0.100 |
Why?
|
Microbial Sensitivity Tests | 5 | 2014 | 1877 | 0.100 |
Why?
|
Transplantation, Heterologous | 4 | 2012 | 2382 | 0.100 |
Why?
|
Multipotent Stem Cells | 1 | 2012 | 186 | 0.100 |
Why?
|
Epoxide Hydrolases | 2 | 2002 | 122 | 0.090 |
Why?
|
Endemic Diseases | 2 | 2008 | 182 | 0.090 |
Why?
|
Respiration, Artificial | 6 | 2009 | 2569 | 0.090 |
Why?
|
Sarcoma, Synovial | 1 | 2012 | 167 | 0.090 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2012 | 602 | 0.090 |
Why?
|
Spinal Neoplasms | 1 | 2017 | 760 | 0.090 |
Why?
|
Peroxidase | 2 | 2004 | 611 | 0.090 |
Why?
|
Endoscopy | 2 | 2011 | 1785 | 0.090 |
Why?
|
Young Adult | 17 | 2015 | 56430 | 0.090 |
Why?
|
Vitamin D | 4 | 2008 | 3223 | 0.090 |
Why?
|
Proteins | 6 | 2004 | 6103 | 0.090 |
Why?
|
Child, Preschool | 23 | 2014 | 41006 | 0.090 |
Why?
|
Pleurodesis | 1 | 2010 | 41 | 0.090 |
Why?
|
Gastroenteritis | 1 | 2012 | 245 | 0.090 |
Why?
|
Rheumatic Heart Disease | 1 | 1991 | 177 | 0.090 |
Why?
|
Sarcoma | 4 | 2011 | 1897 | 0.090 |
Why?
|
Lung Diseases, Interstitial | 1 | 2018 | 808 | 0.090 |
Why?
|
Cattle | 2 | 2013 | 3922 | 0.090 |
Why?
|
Pulmonary Gas Exchange | 4 | 2006 | 382 | 0.090 |
Why?
|
Multidrug Resistance-Associated Proteins | 1 | 2010 | 107 | 0.090 |
Why?
|
Constriction, Pathologic | 3 | 2010 | 1107 | 0.090 |
Why?
|
Sensitivity and Specificity | 10 | 2016 | 14722 | 0.090 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2009 | 2948 | 0.090 |
Why?
|
Adrenalectomy | 1 | 2011 | 341 | 0.090 |
Why?
|
Helicobacter pylori | 2 | 2014 | 382 | 0.090 |
Why?
|
Wales | 3 | 2014 | 85 | 0.090 |
Why?
|
Ciprofloxacin | 1 | 2011 | 315 | 0.090 |
Why?
|
Sodium Selenite | 1 | 2008 | 11 | 0.090 |
Why?
|
Adrenergic alpha-Agonists | 1 | 2010 | 177 | 0.080 |
Why?
|
Matrix Metalloproteinase 3 | 2 | 2008 | 134 | 0.080 |
Why?
|
Base Sequence | 9 | 2009 | 12797 | 0.080 |
Why?
|
Drug Resistance, Microbial | 4 | 2001 | 862 | 0.080 |
Why?
|
Alleles | 12 | 2008 | 6933 | 0.080 |
Why?
|
Gastric Emptying | 1 | 2011 | 233 | 0.080 |
Why?
|
Anti-Infective Agents | 4 | 2004 | 972 | 0.080 |
Why?
|
Multivariate Analysis | 7 | 2015 | 12245 | 0.080 |
Why?
|
Pulmonary Artery | 4 | 2006 | 1912 | 0.080 |
Why?
|
Odds Ratio | 13 | 2010 | 9849 | 0.080 |
Why?
|
Chromosomes, Human, Pair 3 | 2 | 2001 | 323 | 0.080 |
Why?
|
Gene Frequency | 8 | 2009 | 3588 | 0.080 |
Why?
|
Dogs | 1 | 2013 | 3912 | 0.080 |
Why?
|
Brain Death | 1 | 2012 | 348 | 0.080 |
Why?
|
Deglutition Disorders | 3 | 2016 | 605 | 0.080 |
Why?
|
Gram-Negative Bacteria | 1 | 2010 | 270 | 0.080 |
Why?
|
Esophagoplasty | 1 | 2008 | 43 | 0.080 |
Why?
|
Transplantation Chimera | 2 | 2009 | 612 | 0.080 |
Why?
|
Arginine | 4 | 2009 | 944 | 0.080 |
Why?
|
Culture Techniques | 1 | 2008 | 554 | 0.080 |
Why?
|
Mannitol | 1 | 2008 | 181 | 0.080 |
Why?
|
Sister Chromatid Exchange | 3 | 2000 | 60 | 0.080 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2010 | 232 | 0.080 |
Why?
|
Lumbar Vertebrae | 1 | 2017 | 1848 | 0.080 |
Why?
|
Bradycardia | 1 | 2010 | 307 | 0.080 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2012 | 3870 | 0.080 |
Why?
|
Lymphocytes | 6 | 2006 | 2617 | 0.080 |
Why?
|
Nigeria | 1 | 2010 | 733 | 0.080 |
Why?
|
Oseltamivir | 1 | 2008 | 75 | 0.080 |
Why?
|
Receptors, Lysophosphatidic Acid | 1 | 2007 | 76 | 0.080 |
Why?
|
Animals | 41 | 2015 | 168757 | 0.080 |
Why?
|
Pleural Neoplasms | 1 | 2012 | 607 | 0.080 |
Why?
|
Muscle Neoplasms | 1 | 2009 | 139 | 0.080 |
Why?
|
Drug Resistance | 1 | 2013 | 1609 | 0.080 |
Why?
|
RNA, Bacterial | 1 | 2009 | 390 | 0.070 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 3 | 2014 | 143 | 0.070 |
Why?
|
Debridement | 1 | 2010 | 492 | 0.070 |
Why?
|
Laboratories, Hospital | 1 | 2008 | 194 | 0.070 |
Why?
|
Forecasting | 4 | 2012 | 2951 | 0.070 |
Why?
|
Cytochrome P-450 CYP1A1 | 2 | 1997 | 91 | 0.070 |
Why?
|
Cyclin D1 | 1 | 2009 | 463 | 0.070 |
Why?
|
Lung Injury | 2 | 2012 | 436 | 0.070 |
Why?
|
Voice Quality | 2 | 2012 | 217 | 0.070 |
Why?
|
Respiratory Mechanics | 5 | 1998 | 686 | 0.070 |
Why?
|
Histocompatibility Testing | 4 | 2015 | 741 | 0.070 |
Why?
|
Carcinoma | 3 | 2006 | 2375 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 6 | 2015 | 6538 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2010 | 3920 | 0.070 |
Why?
|
Thyroid Neoplasms | 2 | 2007 | 2282 | 0.070 |
Why?
|
Thoracic Surgical Procedures | 2 | 2003 | 342 | 0.070 |
Why?
|
Cytosine | 2 | 1988 | 216 | 0.070 |
Why?
|
Incidence | 9 | 2014 | 20947 | 0.070 |
Why?
|
Tissue Donors | 3 | 2012 | 2240 | 0.070 |
Why?
|
Surgical Wound Dehiscence | 2 | 2004 | 215 | 0.070 |
Why?
|
Oligonucleotides | 1 | 2009 | 572 | 0.070 |
Why?
|
Neurofibromatosis 1 | 1 | 2011 | 569 | 0.070 |
Why?
|
Respiratory Mucosa | 2 | 2012 | 427 | 0.070 |
Why?
|
Salmonella paratyphi A | 1 | 2005 | 47 | 0.070 |
Why?
|
Paratyphoid Fever | 1 | 2005 | 35 | 0.070 |
Why?
|
Models, Animal | 5 | 2015 | 2171 | 0.070 |
Why?
|
DNA, Neoplasm | 4 | 2011 | 1758 | 0.070 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2008 | 472 | 0.070 |
Why?
|
Sheep | 8 | 1997 | 1437 | 0.070 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2014 | 3047 | 0.070 |
Why?
|
Prospective Studies | 17 | 2021 | 53288 | 0.070 |
Why?
|
Dexmedetomidine | 1 | 2010 | 315 | 0.060 |
Why?
|
Esophageal Achalasia | 1 | 2006 | 91 | 0.060 |
Why?
|
Drug Resistance, Multiple | 4 | 2000 | 252 | 0.060 |
Why?
|
Omentum | 2 | 2003 | 170 | 0.060 |
Why?
|
Cryptogenic Organizing Pneumonia | 1 | 2005 | 29 | 0.060 |
Why?
|
Occupational Exposure | 4 | 2001 | 1796 | 0.060 |
Why?
|
Receptors, Leukotriene B4 | 1 | 2005 | 94 | 0.060 |
Why?
|
Population Surveillance | 3 | 2011 | 2616 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 2 | 2012 | 5535 | 0.060 |
Why?
|
Funnel Chest | 1 | 2005 | 71 | 0.060 |
Why?
|
T-Lymphocytes | 6 | 2015 | 10180 | 0.060 |
Why?
|
Folic Acid | 1 | 2012 | 1300 | 0.060 |
Why?
|
Nitric Oxide | 4 | 1998 | 2132 | 0.060 |
Why?
|
Intercostal Muscles | 1 | 2004 | 26 | 0.060 |
Why?
|
Iron, Dietary | 1 | 2005 | 141 | 0.060 |
Why?
|
Promoter Regions, Genetic | 7 | 2012 | 5867 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2014 | 8428 | 0.060 |
Why?
|
Genetic Markers | 3 | 2017 | 2634 | 0.060 |
Why?
|
Chemokines, CXC | 1 | 2006 | 422 | 0.060 |
Why?
|
Embryonic Stem Cells | 1 | 2012 | 1294 | 0.060 |
Why?
|
Respiratory Syncytial Virus Infections | 2 | 2000 | 329 | 0.060 |
Why?
|
Cystadenoma, Mucinous | 1 | 2004 | 59 | 0.060 |
Why?
|
Aorta | 1 | 2012 | 2061 | 0.060 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2012 | 1660 | 0.060 |
Why?
|
Matrix Metalloproteinases | 1 | 2006 | 391 | 0.060 |
Why?
|
Metalloendopeptidases | 1 | 2005 | 396 | 0.060 |
Why?
|
Skin Transplantation | 3 | 2007 | 1074 | 0.060 |
Why?
|
Oxygen Consumption | 4 | 1998 | 1869 | 0.060 |
Why?
|
Asbestosis | 2 | 2001 | 82 | 0.060 |
Why?
|
Preoperative Care | 4 | 2011 | 2250 | 0.060 |
Why?
|
Genes, Bacterial | 2 | 2010 | 1079 | 0.060 |
Why?
|
Thoracic Wall | 1 | 2005 | 203 | 0.060 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2010 | 1122 | 0.060 |
Why?
|
Diarrhea | 1 | 2010 | 1348 | 0.060 |
Why?
|
Regeneration | 1 | 2012 | 1485 | 0.060 |
Why?
|
Length of Stay | 6 | 2012 | 6309 | 0.060 |
Why?
|
Prosthesis Design | 1 | 2010 | 2110 | 0.060 |
Why?
|
Hoarseness | 2 | 2005 | 65 | 0.060 |
Why?
|
Receptors, Chemokine | 1 | 2006 | 669 | 0.050 |
Why?
|
Apoptosis | 2 | 2010 | 9727 | 0.050 |
Why?
|
Thoracic Neoplasms | 2 | 2003 | 268 | 0.050 |
Why?
|
Platinum | 1 | 2004 | 233 | 0.050 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 2 | 2001 | 494 | 0.050 |
Why?
|
Isoantigens | 1 | 2005 | 567 | 0.050 |
Why?
|
Calcium, Dietary | 1 | 2005 | 526 | 0.050 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2005 | 675 | 0.050 |
Why?
|
Macaca fascicularis | 3 | 2015 | 915 | 0.050 |
Why?
|
Postoperative Period | 4 | 2003 | 1842 | 0.050 |
Why?
|
Antineoplastic Agents | 6 | 2011 | 13695 | 0.050 |
Why?
|
Carcinoma, Small Cell | 1 | 2005 | 420 | 0.050 |
Why?
|
Carrier Proteins | 2 | 2010 | 5021 | 0.050 |
Why?
|
Transcription Factors | 4 | 2004 | 12208 | 0.050 |
Why?
|
Infant | 15 | 2014 | 35136 | 0.050 |
Why?
|
Soft Tissue Neoplasms | 1 | 2012 | 1363 | 0.050 |
Why?
|
Ibuprofen | 1 | 2004 | 236 | 0.050 |
Why?
|
Flavonoids | 1 | 2005 | 443 | 0.050 |
Why?
|
Genome, Bacterial | 1 | 2007 | 760 | 0.050 |
Why?
|
Living Donors | 1 | 2006 | 620 | 0.050 |
Why?
|
Dilatation | 1 | 2003 | 291 | 0.050 |
Why?
|
Esophageal Fistula | 1 | 2002 | 64 | 0.050 |
Why?
|
Fluorouracil | 7 | 2006 | 1619 | 0.050 |
Why?
|
Arylamine N-Acetyltransferase | 1 | 2002 | 86 | 0.050 |
Why?
|
Ossification, Heterotopic | 1 | 2004 | 239 | 0.050 |
Why?
|
Bronchoscopes | 1 | 2001 | 64 | 0.050 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2006 | 484 | 0.050 |
Why?
|
Vital Capacity | 4 | 2010 | 925 | 0.050 |
Why?
|
Disease Outbreaks | 1 | 2011 | 1772 | 0.050 |
Why?
|
Quinone Reductases | 1 | 2001 | 18 | 0.050 |
Why?
|
Device Removal | 1 | 2006 | 656 | 0.050 |
Why?
|
Pyrazoles | 1 | 2012 | 1972 | 0.050 |
Why?
|
Phenols | 1 | 2005 | 497 | 0.050 |
Why?
|
Zinc | 1 | 2005 | 684 | 0.050 |
Why?
|
Anesthesia, Epidural | 2 | 1993 | 228 | 0.050 |
Why?
|
Loss of Heterozygosity | 2 | 2001 | 684 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2012 | 5172 | 0.050 |
Why?
|
Cohort Studies | 12 | 2015 | 40561 | 0.050 |
Why?
|
Chest Tubes | 2 | 1999 | 150 | 0.050 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 2002 | 122 | 0.050 |
Why?
|
Vasodilator Agents | 2 | 1998 | 977 | 0.050 |
Why?
|
DNA | 4 | 2005 | 7301 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2011 | 2916 | 0.050 |
Why?
|
Cyclins | 1 | 2003 | 603 | 0.050 |
Why?
|
Shigella sonnei | 1 | 2000 | 3 | 0.050 |
Why?
|
Barrett Esophagus | 1 | 2005 | 494 | 0.050 |
Why?
|
Gene Expression Profiling | 2 | 2014 | 9438 | 0.050 |
Why?
|
Genes, p16 | 1 | 2001 | 157 | 0.050 |
Why?
|
Public Health | 1 | 2014 | 2603 | 0.050 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2012 | 1736 | 0.050 |
Why?
|
Lymphatic System | 1 | 2002 | 253 | 0.050 |
Why?
|
Television | 2 | 1993 | 409 | 0.050 |
Why?
|
Kidney Transplantation | 3 | 2009 | 4251 | 0.050 |
Why?
|
Antilymphocyte Serum | 2 | 2015 | 492 | 0.050 |
Why?
|
Hospital Mortality | 5 | 2012 | 5317 | 0.050 |
Why?
|
Brachial Plexus Neuropathies | 1 | 2002 | 122 | 0.050 |
Why?
|
Smoking Cessation | 5 | 2006 | 2071 | 0.050 |
Why?
|
Cell Line | 2 | 2012 | 15997 | 0.050 |
Why?
|
Esophageal Perforation | 2 | 2003 | 69 | 0.050 |
Why?
|
Proportional Hazards Models | 6 | 2015 | 12354 | 0.050 |
Why?
|
Mutation | 11 | 2012 | 29786 | 0.050 |
Why?
|
Epithelial Cells | 1 | 2012 | 3690 | 0.050 |
Why?
|
Analysis of Variance | 5 | 2015 | 6365 | 0.050 |
Why?
|
Fibrosarcoma | 1 | 2002 | 348 | 0.040 |
Why?
|
Bronchoalveolar Lavage Fluid | 2 | 2007 | 768 | 0.040 |
Why?
|
Confidence Intervals | 5 | 2008 | 2971 | 0.040 |
Why?
|
Valine | 1 | 2001 | 413 | 0.040 |
Why?
|
Pyridines | 1 | 2012 | 2825 | 0.040 |
Why?
|
Cicatrix | 2 | 2003 | 764 | 0.040 |
Why?
|
Acetaminophen | 1 | 2004 | 545 | 0.040 |
Why?
|
Pulmonary Ventilation | 2 | 1998 | 373 | 0.040 |
Why?
|
Trans-Activators | 1 | 2010 | 2924 | 0.040 |
Why?
|
Forced Expiratory Volume | 4 | 2010 | 1743 | 0.040 |
Why?
|
Genes, MHC Class II | 1 | 2000 | 457 | 0.040 |
Why?
|
Heart Arrest | 1 | 2010 | 1470 | 0.040 |
Why?
|
Dysentery, Bacillary | 1 | 2000 | 75 | 0.040 |
Why?
|
Age of Onset | 1 | 2006 | 3271 | 0.040 |
Why?
|
Point Mutation | 2 | 2002 | 1623 | 0.040 |
Why?
|
Hemodynamics | 3 | 1999 | 4199 | 0.040 |
Why?
|
Genomic Islands | 2 | 2011 | 51 | 0.040 |
Why?
|
Adenocarcinoma, Bronchiolo-Alveolar | 1 | 1999 | 91 | 0.040 |
Why?
|
Leiomyoma | 1 | 2005 | 730 | 0.040 |
Why?
|
Risk Assessment | 10 | 2018 | 23338 | 0.040 |
Why?
|
Alanine | 1 | 2001 | 572 | 0.040 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2003 | 903 | 0.040 |
Why?
|
Statistics, Nonparametric | 4 | 2012 | 2886 | 0.040 |
Why?
|
Ventilators, Mechanical | 1 | 2001 | 292 | 0.040 |
Why?
|
Penicillin V | 1 | 1998 | 18 | 0.040 |
Why?
|
Recurrence | 5 | 2006 | 8340 | 0.040 |
Why?
|
Carcinogens, Environmental | 1 | 1999 | 67 | 0.040 |
Why?
|
Complement C3b | 1 | 1999 | 106 | 0.040 |
Why?
|
Shigella flexneri | 1 | 2000 | 132 | 0.040 |
Why?
|
Serine | 1 | 2003 | 826 | 0.040 |
Why?
|
Respiratory Tract Neoplasms | 1 | 1999 | 57 | 0.040 |
Why?
|
Penicillin G | 1 | 1998 | 42 | 0.040 |
Why?
|
Complement Membrane Attack Complex | 1 | 1999 | 112 | 0.040 |
Why?
|
Pulmonary Emphysema | 2 | 2014 | 672 | 0.040 |
Why?
|
Factor Analysis, Statistical | 2 | 2012 | 977 | 0.040 |
Why?
|
Leukocytes | 3 | 2007 | 2043 | 0.040 |
Why?
|
Nausea | 2 | 2016 | 673 | 0.040 |
Why?
|
Melanoma, Experimental | 1 | 2002 | 561 | 0.040 |
Why?
|
Diphtheria | 1 | 1998 | 35 | 0.040 |
Why?
|
Erythromycin | 1 | 1998 | 120 | 0.040 |
Why?
|
Carcinoma, Large Cell | 3 | 2008 | 113 | 0.040 |
Why?
|
Complement C4b | 1 | 1999 | 135 | 0.040 |
Why?
|
Fetal Tissue Transplantation | 1 | 1999 | 139 | 0.040 |
Why?
|
Mediastinal Cyst | 1 | 1998 | 29 | 0.040 |
Why?
|
Tacrolimus | 3 | 2007 | 743 | 0.040 |
Why?
|
MicroRNAs | 1 | 2014 | 3752 | 0.040 |
Why?
|
Acid Anhydride Hydrolases | 1 | 1998 | 72 | 0.040 |
Why?
|
Chi-Square Distribution | 3 | 2012 | 3508 | 0.040 |
Why?
|
Cation Transport Proteins | 1 | 2001 | 327 | 0.040 |
Why?
|
Exons | 3 | 1999 | 2437 | 0.040 |
Why?
|
Complement C4 | 1 | 1999 | 257 | 0.040 |
Why?
|
RNA, Messenger | 6 | 2012 | 13033 | 0.040 |
Why?
|
Histoplasmosis | 1 | 1998 | 66 | 0.040 |
Why?
|
Neurilemmoma | 1 | 2003 | 547 | 0.040 |
Why?
|
Pulmonary Alveoli | 2 | 2006 | 675 | 0.040 |
Why?
|
ACTH Syndrome, Ectopic | 1 | 1997 | 30 | 0.040 |
Why?
|
Suture Techniques | 3 | 1999 | 798 | 0.040 |
Why?
|
Waiting Lists | 1 | 2002 | 692 | 0.040 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2004 | 2016 | 0.040 |
Why?
|
Sex Factors | 9 | 2004 | 10397 | 0.040 |
Why?
|
Endothelium, Vascular | 2 | 2004 | 4456 | 0.040 |
Why?
|
Perfusion | 1 | 2002 | 1360 | 0.040 |
Why?
|
Body Mass Index | 3 | 2011 | 12720 | 0.040 |
Why?
|
Drug Administration Schedule | 4 | 2016 | 4933 | 0.040 |
Why?
|
Esophagogastric Junction | 2 | 2016 | 313 | 0.040 |
Why?
|
Boston | 5 | 2012 | 9313 | 0.040 |
Why?
|
Matrix Metalloproteinase 12 | 2 | 2008 | 49 | 0.040 |
Why?
|
Antiviral Agents | 2 | 2008 | 2987 | 0.040 |
Why?
|
Disease Progression | 1 | 2014 | 13284 | 0.040 |
Why?
|
Fibroblasts | 1 | 2007 | 4161 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 9 | 2004 | 20129 | 0.040 |
Why?
|
DNA Methylation | 2 | 2001 | 4286 | 0.040 |
Why?
|
Administration, Inhalation | 5 | 2000 | 1105 | 0.040 |
Why?
|
Opportunistic Infections | 1 | 2000 | 389 | 0.040 |
Why?
|
Ribs | 1 | 1998 | 252 | 0.040 |
Why?
|
Molecular Sequence Data | 7 | 2002 | 18111 | 0.040 |
Why?
|
Laparoscopy | 1 | 2009 | 2151 | 0.040 |
Why?
|
Influenza, Human | 1 | 2008 | 1479 | 0.040 |
Why?
|
Vascular Neoplasms | 1 | 1998 | 175 | 0.040 |
Why?
|
Muscle Contraction | 4 | 1997 | 1240 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2011 | 5853 | 0.040 |
Why?
|
Pilot Projects | 5 | 2018 | 8324 | 0.040 |
Why?
|
Feasibility Studies | 5 | 2008 | 5078 | 0.030 |
Why?
|
Homozygote | 4 | 2006 | 1785 | 0.030 |
Why?
|
Larynx | 3 | 2011 | 494 | 0.030 |
Why?
|
Hypoxanthine Phosphoribosyltransferase | 1 | 1995 | 68 | 0.030 |
Why?
|
Risk | 3 | 2005 | 9687 | 0.030 |
Why?
|
Micronuclei, Chromosome-Defective | 1 | 1996 | 38 | 0.030 |
Why?
|
Penicillins | 1 | 1998 | 380 | 0.030 |
Why?
|
Anorexia | 1 | 2016 | 161 | 0.030 |
Why?
|
Blood | 1 | 1998 | 598 | 0.030 |
Why?
|
Cushing Syndrome | 1 | 1997 | 249 | 0.030 |
Why?
|
Radiography | 5 | 2005 | 7023 | 0.030 |
Why?
|
Salmonella | 2 | 2012 | 129 | 0.030 |
Why?
|
Bangladesh | 1 | 2017 | 687 | 0.030 |
Why?
|
Environmental Exposure | 3 | 1999 | 4234 | 0.030 |
Why?
|
Peptides | 1 | 2007 | 4409 | 0.030 |
Why?
|
Diet | 5 | 2007 | 7939 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 2005 | 2866 | 0.030 |
Why?
|
Polymorphism, Single-Stranded Conformational | 3 | 2001 | 335 | 0.030 |
Why?
|
Cancer Vaccines | 1 | 2003 | 1023 | 0.030 |
Why?
|
Papio | 3 | 2003 | 656 | 0.030 |
Why?
|
Asia | 2 | 2008 | 610 | 0.030 |
Why?
|
Catheter Ablation | 1 | 2008 | 2758 | 0.030 |
Why?
|
Species Specificity | 2 | 2013 | 2478 | 0.030 |
Why?
|
Paclitaxel | 2 | 2004 | 1708 | 0.030 |
Why?
|
Neoplasms, Multiple Primary | 1 | 1999 | 604 | 0.030 |
Why?
|
Thorax | 3 | 1994 | 547 | 0.030 |
Why?
|
Probability | 3 | 2008 | 2505 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2002 | 2216 | 0.030 |
Why?
|
Carbon Dioxide | 4 | 2006 | 1150 | 0.030 |
Why?
|
Microsatellite Repeats | 3 | 2001 | 802 | 0.030 |
Why?
|
Horses | 1 | 2015 | 304 | 0.030 |
Why?
|
Dietary Supplements | 1 | 2007 | 3297 | 0.030 |
Why?
|
Elastin | 1 | 1995 | 308 | 0.030 |
Why?
|
Blood Loss, Surgical | 1 | 1998 | 662 | 0.030 |
Why?
|
Radiotherapy Dosage | 4 | 2004 | 2879 | 0.030 |
Why?
|
Proline | 2 | 2009 | 458 | 0.030 |
Why?
|
Antifungal Agents | 1 | 1999 | 730 | 0.030 |
Why?
|
Interleukin-1 | 2 | 2012 | 1263 | 0.030 |
Why?
|
Regression Analysis | 4 | 2014 | 6459 | 0.030 |
Why?
|
Mice, Inbred BALB C | 3 | 2010 | 6386 | 0.030 |
Why?
|
Administration, Oral | 2 | 2016 | 3913 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2005 | 3768 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2004 | 2282 | 0.030 |
Why?
|
Antioxidants | 3 | 1998 | 1663 | 0.030 |
Why?
|
Exercise Tolerance | 1 | 1998 | 770 | 0.030 |
Why?
|
Evolution, Molecular | 1 | 2002 | 1940 | 0.030 |
Why?
|
Receptors, Interleukin-6 | 1 | 2015 | 224 | 0.030 |
Why?
|
Animal Feed | 1 | 2013 | 110 | 0.030 |
Why?
|
Birds | 1 | 2014 | 163 | 0.030 |
Why?
|
Sequence Deletion | 1 | 1998 | 1526 | 0.030 |
Why?
|
Antibiotic Prophylaxis | 1 | 1999 | 639 | 0.030 |
Why?
|
Critical Pathways | 1 | 1997 | 476 | 0.030 |
Why?
|
Safety | 1 | 1998 | 1186 | 0.030 |
Why?
|
Acidosis, Respiratory | 1 | 1993 | 37 | 0.030 |
Why?
|
Health Status | 1 | 2006 | 4034 | 0.030 |
Why?
|
Video Recording | 1 | 1998 | 949 | 0.030 |
Why?
|
Internship and Residency | 1 | 1993 | 5788 | 0.030 |
Why?
|
Digoxin | 1 | 1994 | 250 | 0.030 |
Why?
|
Hemangioma | 1 | 1998 | 738 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 2009 | 4253 | 0.030 |
Why?
|
Immunity, Innate | 2 | 2005 | 2958 | 0.030 |
Why?
|
Camptothecin | 1 | 2016 | 576 | 0.030 |
Why?
|
Meningioma | 1 | 2002 | 1209 | 0.030 |
Why?
|
Respiratory Function Tests | 3 | 2008 | 1616 | 0.030 |
Why?
|
Lymph Node Excision | 2 | 2015 | 1261 | 0.030 |
Why?
|
Aminophylline | 1 | 1992 | 40 | 0.030 |
Why?
|
Pulmonary Fibrosis | 2 | 2007 | 530 | 0.030 |
Why?
|
Neoplasm Proteins | 2 | 2011 | 3703 | 0.030 |
Why?
|
Radiography, Thoracic | 2 | 2001 | 1265 | 0.030 |
Why?
|
Sapovirus | 1 | 2012 | 5 | 0.030 |
Why?
|
Pneumonia, Bacterial | 1 | 1995 | 316 | 0.030 |
Why?
|
Severity of Illness Index | 5 | 2014 | 15540 | 0.030 |
Why?
|
Meningeal Neoplasms | 1 | 2002 | 1241 | 0.030 |
Why?
|
Sulfur Dioxide | 1 | 2012 | 177 | 0.030 |
Why?
|
Campylobacter | 1 | 2012 | 59 | 0.030 |
Why?
|
Mental Health | 1 | 2006 | 3019 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2003 | 3798 | 0.030 |
Why?
|
Norovirus | 1 | 2012 | 35 | 0.030 |
Why?
|
Spices | 1 | 2011 | 10 | 0.030 |
Why?
|
Hernia, Diaphragmatic | 1 | 1993 | 250 | 0.030 |
Why?
|
Ovarian Neoplasms | 1 | 2009 | 4838 | 0.030 |
Why?
|
Speech Intelligibility | 1 | 2012 | 81 | 0.030 |
Why?
|
History, 20th Century | 1 | 2000 | 2740 | 0.030 |
Why?
|
Laminectomy | 2 | 2003 | 234 | 0.030 |
Why?
|
Salmonella enteritidis | 1 | 2011 | 17 | 0.030 |
Why?
|
Macrophages | 2 | 2010 | 5655 | 0.030 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2005 | 4479 | 0.030 |
Why?
|
Radiotherapy | 3 | 2006 | 1533 | 0.030 |
Why?
|
Africa, Northern | 1 | 2011 | 82 | 0.020 |
Why?
|
Time-Lapse Imaging | 1 | 2012 | 195 | 0.020 |
Why?
|
Jejunum | 1 | 1993 | 480 | 0.020 |
Why?
|
Infusions, Intravenous | 3 | 2010 | 2274 | 0.020 |
Why?
|
Signal Transduction | 2 | 2012 | 23403 | 0.020 |
Why?
|
Equipment Failure | 1 | 1994 | 578 | 0.020 |
Why?
|
Germany | 1 | 2013 | 862 | 0.020 |
Why?
|
Equipment Design | 2 | 2003 | 3582 | 0.020 |
Why?
|
Mice | 9 | 2012 | 81183 | 0.020 |
Why?
|
Cell Tracking | 1 | 2012 | 145 | 0.020 |
Why?
|
Vacuolar Proton-Translocating ATPases | 1 | 2012 | 195 | 0.020 |
Why?
|
Pressure | 2 | 2006 | 1203 | 0.020 |
Why?
|
Middle East | 1 | 2011 | 219 | 0.020 |
Why?
|
Mediastinum | 2 | 2008 | 267 | 0.020 |
Why?
|
Exercise Test | 4 | 2002 | 2074 | 0.020 |
Why?
|
Deglutition | 1 | 2012 | 197 | 0.020 |
Why?
|
Tomography, Emission-Computed | 2 | 2005 | 1144 | 0.020 |
Why?
|
Syndrome | 2 | 2008 | 3251 | 0.020 |
Why?
|
Disaccharides | 2 | 2003 | 171 | 0.020 |
Why?
|
Monocytes | 1 | 2000 | 2596 | 0.020 |
Why?
|
Glucose | 1 | 2002 | 4397 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2013 | 767 | 0.020 |
Why?
|
Reference Values | 3 | 2002 | 4982 | 0.020 |
Why?
|
Interviews as Topic | 2 | 2008 | 2539 | 0.020 |
Why?
|
Seasons | 2 | 2007 | 1493 | 0.020 |
Why?
|
Anesthesia | 1 | 2001 | 1561 | 0.020 |
Why?
|
Disease Models, Animal | 3 | 2006 | 18029 | 0.020 |
Why?
|
Vinblastine | 2 | 2006 | 502 | 0.020 |
Why?
|
Arteriovenous Malformations | 1 | 1993 | 396 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2012 | 4420 | 0.020 |
Why?
|
Methods | 3 | 1996 | 1129 | 0.020 |
Why?
|
France | 1 | 2011 | 517 | 0.020 |
Why?
|
Membrane Proteins | 2 | 2011 | 7880 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2015 | 2124 | 0.020 |
Why?
|
Porins | 1 | 2010 | 81 | 0.020 |
Why?
|
Eggs | 1 | 2011 | 184 | 0.020 |
Why?
|
Protein Array Analysis | 1 | 2011 | 411 | 0.020 |
Why?
|
Immunohistochemistry | 3 | 2012 | 11366 | 0.020 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2011 | 440 | 0.020 |
Why?
|
Diet, Vegetarian | 1 | 2011 | 174 | 0.020 |
Why?
|
Linkage Disequilibrium | 2 | 2005 | 1997 | 0.020 |
Why?
|
Mice, Inbred C57BL | 4 | 2010 | 21827 | 0.020 |
Why?
|
Cocarcinogenesis | 2 | 1999 | 54 | 0.020 |
Why?
|
Denmark | 1 | 2011 | 738 | 0.020 |
Why?
|
Suction | 1 | 1990 | 267 | 0.020 |
Why?
|
Organ Specificity | 1 | 2014 | 2008 | 0.020 |
Why?
|
Netherlands | 1 | 2013 | 2170 | 0.020 |
Why?
|
Causality | 1 | 2015 | 1275 | 0.020 |
Why?
|
Acute Disease | 3 | 2005 | 7149 | 0.020 |
Why?
|
Immunoblotting | 1 | 2012 | 1682 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2012 | 1547 | 0.020 |
Why?
|
Postoperative Care | 2 | 1992 | 1486 | 0.020 |
Why?
|
Immunoglobulin M | 2 | 2006 | 1537 | 0.020 |
Why?
|
Genetic Linkage | 1 | 2014 | 2421 | 0.020 |
Why?
|
Restaurants | 1 | 2011 | 236 | 0.020 |
Why?
|
Immunologic Memory | 1 | 2015 | 1348 | 0.020 |
Why?
|
Surgical Procedures, Operative | 2 | 2004 | 1876 | 0.020 |
Why?
|
Immunocompromised Host | 2 | 2006 | 847 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2006 | 5256 | 0.020 |
Why?
|
Sputum | 1 | 1990 | 476 | 0.020 |
Why?
|
Walking | 1 | 1995 | 1180 | 0.020 |
Why?
|
Whole-Body Irradiation | 1 | 2009 | 449 | 0.020 |
Why?
|
Fas Ligand Protein | 1 | 2008 | 216 | 0.020 |
Why?
|
Crows | 1 | 2007 | 5 | 0.020 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1994 | 1504 | 0.020 |
Why?
|
Cardiac Surgical Procedures | 1 | 2003 | 3537 | 0.020 |
Why?
|
Hospitals, General | 1 | 2012 | 749 | 0.020 |
Why?
|
Esophagitis, Peptic | 1 | 2008 | 78 | 0.020 |
Why?
|
Organ Transplantation | 1 | 1998 | 1139 | 0.020 |
Why?
|
Vasodilation | 1 | 1991 | 944 | 0.020 |
Why?
|
Pulmonary Veins | 1 | 1993 | 761 | 0.020 |
Why?
|
Prophages | 1 | 2007 | 38 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2012 | 1878 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2008 | 3479 | 0.020 |
Why?
|
Predictive Value of Tests | 4 | 2007 | 15076 | 0.020 |
Why?
|
Methylation | 2 | 1988 | 1106 | 0.020 |
Why?
|
Salmonella Infections, Animal | 1 | 2007 | 65 | 0.020 |
Why?
|
Cytokines | 1 | 2002 | 7322 | 0.020 |
Why?
|
DNA Fingerprinting | 1 | 2007 | 112 | 0.020 |
Why?
|
Mice, Knockout | 3 | 2007 | 14557 | 0.020 |
Why?
|
Ribavirin | 2 | 2000 | 395 | 0.020 |
Why?
|
Carcinoma, Papillary | 1 | 1992 | 783 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2012 | 2088 | 0.020 |
Why?
|
CpG Islands | 2 | 2001 | 1172 | 0.020 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 2006 | 88 | 0.020 |
Why?
|
DNA Restriction Enzymes | 1 | 1986 | 570 | 0.020 |
Why?
|
Quality Assurance, Health Care | 1 | 1997 | 2212 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2010 | 1005 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 2011 | 1097 | 0.020 |
Why?
|
Vascular Patency | 1 | 2009 | 886 | 0.020 |
Why?
|
Bleomycin | 1 | 2007 | 512 | 0.020 |
Why?
|
Mice, SCID | 1 | 2012 | 2716 | 0.020 |
Why?
|
Cell Migration Inhibition | 1 | 2006 | 96 | 0.020 |
Why?
|
Total Lung Capacity | 1 | 2006 | 143 | 0.020 |
Why?
|
Chronic Disease | 4 | 2005 | 9146 | 0.020 |
Why?
|
ABO Blood-Group System | 1 | 2009 | 367 | 0.020 |
Why?
|
Statistics as Topic | 2 | 2003 | 2373 | 0.020 |
Why?
|
Interleukin-10 | 1 | 2012 | 1200 | 0.020 |
Why?
|
Education, Medical, Continuing | 1 | 2012 | 840 | 0.020 |
Why?
|
Chemokine CXCL9 | 1 | 2006 | 132 | 0.020 |
Why?
|
Gastrostomy | 1 | 2008 | 309 | 0.020 |
Why?
|
Peptide Fragments | 1 | 1999 | 5097 | 0.020 |
Why?
|
Life Tables | 1 | 2006 | 370 | 0.020 |
Why?
|
Sex Distribution | 2 | 2002 | 2297 | 0.020 |
Why?
|
Phrenic Nerve | 2 | 1997 | 79 | 0.020 |
Why?
|
Blood Cell Count | 1 | 2006 | 403 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 2008 | 1681 | 0.020 |
Why?
|
Diagnostic Tests, Routine | 1 | 2011 | 783 | 0.020 |
Why?
|
Surgical Stapling | 1 | 2006 | 97 | 0.020 |
Why?
|
Ifosfamide | 1 | 2006 | 228 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2001 | 1157 | 0.020 |
Why?
|
Electromyography | 3 | 1997 | 1379 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2012 | 2649 | 0.020 |
Why?
|
Educational Status | 3 | 1998 | 2540 | 0.020 |
Why?
|
Polypropylenes | 1 | 2005 | 64 | 0.020 |
Why?
|
Age Distribution | 2 | 2002 | 2902 | 0.020 |
Why?
|
alpha-Fetoproteins | 1 | 2006 | 224 | 0.020 |
Why?
|
Lymph Nodes | 2 | 1999 | 3474 | 0.020 |
Why?
|
Oncogenes | 1 | 2011 | 1265 | 0.020 |
Why?
|
Fundoplication | 1 | 2006 | 138 | 0.020 |
Why?
|
Travel | 1 | 2011 | 788 | 0.020 |
Why?
|
Lysophospholipids | 1 | 2007 | 331 | 0.020 |
Why?
|
Gastroscopy | 1 | 2006 | 207 | 0.020 |
Why?
|
Toll-Like Receptor 5 | 1 | 2005 | 39 | 0.020 |
Why?
|
Receptors, CXCR3 | 1 | 2006 | 237 | 0.020 |
Why?
|
Chemokine CXCL10 | 1 | 2006 | 304 | 0.020 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2008 | 629 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2012 | 2699 | 0.020 |
Why?
|
STAT1 Transcription Factor | 1 | 2006 | 320 | 0.020 |
Why?
|
Granulation Tissue | 1 | 2004 | 93 | 0.020 |
Why?
|
ROC Curve | 1 | 2012 | 3527 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2010 | 1364 | 0.020 |
Why?
|
Fellowships and Scholarships | 1 | 1993 | 1076 | 0.020 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2005 | 88 | 0.020 |
Why?
|
Methyl Ethers | 1 | 2006 | 205 | 0.020 |
Why?
|
HL-60 Cells | 1 | 2005 | 365 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2018 | 4042 | 0.020 |
Why?
|
Rats, Inbred WF | 1 | 2004 | 140 | 0.020 |
Why?
|
Hypersensitivity, Delayed | 1 | 2005 | 484 | 0.020 |
Why?
|
Quinazolines | 1 | 2011 | 1356 | 0.020 |
Why?
|
Flagellin | 1 | 2005 | 125 | 0.020 |
Why?
|
Epitopes | 2 | 2003 | 2571 | 0.020 |
Why?
|
Sepsis | 1 | 1998 | 2593 | 0.020 |
Why?
|
Perioperative Care | 1 | 2012 | 1002 | 0.020 |
Why?
|
Technetium Tc 99m Medronate | 1 | 2004 | 136 | 0.020 |
Why?
|
Infant, Newborn | 4 | 2008 | 25625 | 0.010 |
Why?
|
Tidal Volume | 1 | 2006 | 490 | 0.010 |
Why?
|
Physical Endurance | 1 | 2006 | 370 | 0.010 |
Why?
|
Algorithms | 4 | 2009 | 13881 | 0.010 |
Why?
|
Hemoptysis | 1 | 2005 | 155 | 0.010 |
Why?
|
Vitamin A | 2 | 1998 | 615 | 0.010 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2008 | 841 | 0.010 |
Why?
|
Quality of Life | 3 | 2012 | 12804 | 0.010 |
Why?
|
Ovalbumin | 1 | 2005 | 719 | 0.010 |
Why?
|
Tissue and Organ Harvesting | 1 | 2006 | 369 | 0.010 |
Why?
|
Mediastinitis | 1 | 2003 | 48 | 0.010 |
Why?
|
Stem Cell Transplantation | 1 | 2012 | 1620 | 0.010 |
Why?
|
Intestinal Pseudo-Obstruction | 1 | 2003 | 48 | 0.010 |
Why?
|
Mitral Valve | 1 | 1991 | 1491 | 0.010 |
Why?
|
Coronary Angiography | 1 | 1995 | 4577 | 0.010 |
Why?
|
Neoplasm Transplantation | 2 | 2002 | 2085 | 0.010 |
Why?
|
Treatment Failure | 2 | 2000 | 2618 | 0.010 |
Why?
|
Interleukin-1beta | 1 | 2008 | 972 | 0.010 |
Why?
|
Genetic Code | 1 | 2003 | 154 | 0.010 |
Why?
|
Stroke Volume | 3 | 2002 | 5007 | 0.010 |
Why?
|
Heart Valve Prosthesis | 1 | 1991 | 1488 | 0.010 |
Why?
|
Wound Healing | 2 | 2004 | 2785 | 0.010 |
Why?
|
Residual Volume | 1 | 2002 | 41 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2003 | 365 | 0.010 |
Why?
|
Remission Induction | 1 | 2008 | 2386 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 2007 | 1586 | 0.010 |
Why?
|
Heterozygote | 2 | 2001 | 2804 | 0.010 |
Why?
|
Prostaglandin Endoperoxides, Synthetic | 2 | 1991 | 58 | 0.010 |
Why?
|
Reproducibility of Results | 3 | 2012 | 19905 | 0.010 |
Why?
|
Muscle, Smooth | 1 | 2006 | 934 | 0.010 |
Why?
|
Self Disclosure | 1 | 2003 | 251 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2012 | 3200 | 0.010 |
Why?
|
Posture | 2 | 1998 | 958 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2002 | 126 | 0.010 |
Why?
|
Drug Therapy | 1 | 2005 | 497 | 0.010 |
Why?
|
Vomiting | 1 | 2005 | 636 | 0.010 |
Why?
|
Thyroidectomy | 1 | 2007 | 879 | 0.010 |
Why?
|
Cough | 1 | 2005 | 555 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 1997 | 4931 | 0.010 |
Why?
|
Minor Histocompatibility Loci | 1 | 2001 | 18 | 0.010 |
Why?
|
Aortic Valve | 1 | 1991 | 1922 | 0.010 |
Why?
|
Lymphography | 1 | 2002 | 201 | 0.010 |
Why?
|
Toll-Like Receptors | 1 | 2005 | 592 | 0.010 |
Why?
|
Drug Combinations | 1 | 2006 | 1959 | 0.010 |
Why?
|
Tumor Suppressor Protein p14ARF | 1 | 2001 | 90 | 0.010 |
Why?
|
Receptors, Interleukin-1 | 1 | 2002 | 262 | 0.010 |
Why?
|
Immunoglobulin G | 2 | 2006 | 4560 | 0.010 |
Why?
|
Isoantibodies | 1 | 2005 | 679 | 0.010 |
Why?
|
Cause of Death | 1 | 1992 | 3584 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2011 | 2915 | 0.010 |
Why?
|
Pancreatectomy | 1 | 2006 | 804 | 0.010 |
Why?
|
Massachusetts | 2 | 2005 | 8663 | 0.010 |
Why?
|
Drainage | 1 | 2006 | 1142 | 0.010 |
Why?
|
HLA Antigens | 1 | 2006 | 1381 | 0.010 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2002 | 876 | 0.010 |
Why?
|
Hematologic Diseases | 1 | 2005 | 498 | 0.010 |
Why?
|
Respiratory Sounds | 1 | 2005 | 696 | 0.010 |
Why?
|
Lymphotoxin-alpha | 1 | 2000 | 96 | 0.010 |
Why?
|
Mice, Inbred C3H | 1 | 2002 | 964 | 0.010 |
Why?
|
Caenorhabditis elegans | 1 | 2010 | 1419 | 0.010 |
Why?
|
Colectomy | 1 | 2006 | 683 | 0.010 |
Why?
|
Immunization | 1 | 2005 | 1256 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2009 | 2765 | 0.010 |
Why?
|
Animals, Newborn | 2 | 1999 | 2726 | 0.010 |
Why?
|
HLA-DQ Antigens | 1 | 2000 | 210 | 0.010 |
Why?
|
Lidocaine | 2 | 1993 | 544 | 0.010 |
Why?
|
Mice, Nude | 2 | 2002 | 3689 | 0.010 |
Why?
|
Fluoroquinolones | 1 | 2002 | 310 | 0.010 |
Why?
|
Patient Satisfaction | 2 | 2006 | 3396 | 0.010 |
Why?
|
Extracellular Space | 1 | 2002 | 594 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2011 | 2727 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2007 | 2715 | 0.010 |
Why?
|
Agglutination Tests | 1 | 1999 | 41 | 0.010 |
Why?
|
Complement C3 Convertase, Alternative Pathway | 1 | 1999 | 7 | 0.010 |
Why?
|
Endothelial Growth Factors | 1 | 2002 | 694 | 0.010 |
Why?
|
Reperfusion Injury | 1 | 2006 | 1026 | 0.010 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2009 | 1390 | 0.010 |
Why?
|
Vascular Resistance | 2 | 1993 | 936 | 0.010 |
Why?
|
Comorbidity | 1 | 2014 | 10388 | 0.010 |
Why?
|
Vesicular Transport Proteins | 1 | 2002 | 377 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2005 | 12959 | 0.010 |
Why?
|
Radionuclide Ventriculography | 1 | 1998 | 41 | 0.010 |
Why?
|
Stem Cells | 1 | 2012 | 3567 | 0.010 |
Why?
|
Sclerosis | 1 | 1999 | 213 | 0.010 |
Why?
|
Corynebacterium diphtheriae | 1 | 1998 | 22 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2008 | 4186 | 0.010 |
Why?
|
Hospitalization | 2 | 2014 | 10262 | 0.010 |
Why?
|
Ligands | 1 | 2006 | 3282 | 0.010 |
Why?
|
HLA-DR Antigens | 1 | 2000 | 645 | 0.010 |
Why?
|
Aerobiosis | 1 | 1998 | 106 | 0.010 |
Why?
|
Hypersensitivity | 1 | 2007 | 1102 | 0.010 |
Why?
|
O Antigens | 1 | 1999 | 193 | 0.010 |
Why?
|
Autoradiography | 1 | 1999 | 745 | 0.010 |
Why?
|
Gene Deletion | 1 | 2006 | 2751 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2001 | 705 | 0.010 |
Why?
|
Poisson Distribution | 1 | 1999 | 513 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2014 | 13989 | 0.010 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 1998 | 107 | 0.010 |
Why?
|
Antigens, Surface | 1 | 2002 | 1663 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2006 | 3206 | 0.010 |
Why?
|
Bronchitis | 1 | 1998 | 201 | 0.010 |
Why?
|
Genetics, Population | 1 | 2002 | 934 | 0.010 |
Why?
|
Prevalence | 3 | 2001 | 15226 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2008 | 2635 | 0.010 |
Why?
|
Stromal Cells | 1 | 2003 | 1355 | 0.010 |
Why?
|
Morbidity | 1 | 2003 | 1769 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2008 | 2585 | 0.010 |
Why?
|
Methylprednisolone | 1 | 1999 | 387 | 0.010 |
Why?
|
Dyspnea | 1 | 2005 | 1303 | 0.010 |
Why?
|
beta Carotene | 1 | 1998 | 527 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2002 | 1850 | 0.010 |
Why?
|
Complement Activation | 1 | 1999 | 453 | 0.010 |
Why?
|
Lymphocyte Depletion | 1 | 1999 | 608 | 0.010 |
Why?
|
Up-Regulation | 1 | 2006 | 4217 | 0.010 |
Why?
|
Microscopy | 1 | 2002 | 903 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2001 | 1730 | 0.010 |
Why?
|
Anticarcinogenic Agents | 1 | 1998 | 253 | 0.010 |
Why?
|
Decompression, Surgical | 1 | 2002 | 594 | 0.010 |
Why?
|
Collagen | 1 | 2005 | 2689 | 0.010 |
Why?
|
Biocompatible Materials | 1 | 2005 | 1736 | 0.010 |
Why?
|
Databases, Factual | 1 | 2012 | 7729 | 0.010 |
Why?
|
Models, Chemical | 1 | 1999 | 626 | 0.010 |
Why?
|
Esophagitis | 1 | 1997 | 152 | 0.010 |
Why?
|
Micronucleus Tests | 1 | 1996 | 23 | 0.010 |
Why?
|
Membrane Transport Proteins | 1 | 2002 | 1028 | 0.010 |
Why?
|
Mucins | 1 | 1999 | 564 | 0.010 |
Why?
|
Cardiac Output | 1 | 1998 | 854 | 0.010 |
Why?
|
Pneumonia | 1 | 2008 | 2133 | 0.010 |
Why?
|
Hydroxides | 1 | 1995 | 47 | 0.010 |
Why?
|
Lactates | 1 | 1997 | 432 | 0.010 |
Why?
|
Potassium Compounds | 1 | 1995 | 40 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 1994 | 12072 | 0.010 |
Why?
|
Transplantation Conditioning | 1 | 2003 | 1598 | 0.010 |
Why?
|
Urban Health | 1 | 1998 | 547 | 0.010 |
Why?
|
Phosphorus | 1 | 1997 | 338 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2011 | 7913 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 2002 | 1782 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2006 | 4851 | 0.010 |
Why?
|
Empyema | 1 | 1995 | 41 | 0.010 |
Why?
|
Models, Biological | 2 | 2007 | 9583 | 0.010 |
Why?
|
Laryngeal Cartilages | 1 | 1995 | 22 | 0.010 |
Why?
|
Models, Statistical | 2 | 2001 | 5102 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2003 | 1678 | 0.010 |
Why?
|
Maximal Expiratory Flow-Volume Curves | 1 | 1994 | 25 | 0.010 |
Why?
|
Carotenoids | 1 | 1998 | 624 | 0.010 |
Why?
|
Heart Rate | 2 | 1999 | 4091 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2012 | 16689 | 0.010 |
Why?
|
Hydrocarbons | 1 | 1995 | 106 | 0.010 |
Why?
|
Inflammation | 1 | 2015 | 10638 | 0.010 |
Why?
|
Ascorbic Acid | 1 | 1998 | 651 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 1995 | 6487 | 0.010 |
Why?
|
Cost Control | 1 | 1997 | 624 | 0.010 |
Why?
|
Decision Making | 1 | 2009 | 3887 | 0.010 |
Why?
|
Neoplasm, Residual | 1 | 1999 | 973 | 0.010 |
Why?
|
Linear Models | 2 | 1995 | 5952 | 0.010 |
Why?
|
United States | 2 | 2013 | 69872 | 0.010 |
Why?
|
Immunity, Cellular | 1 | 2001 | 1607 | 0.010 |
Why?
|
Gastrointestinal Diseases | 1 | 2003 | 1170 | 0.010 |
Why?
|
Gene Silencing | 1 | 2001 | 1538 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2004 | 2645 | 0.010 |
Why?
|
Blood Gas Analysis | 1 | 1995 | 383 | 0.010 |
Why?
|
Survivors | 1 | 2004 | 2291 | 0.010 |
Why?
|
Mitosis | 1 | 1999 | 1208 | 0.010 |
Why?
|
Muscle Fibers, Skeletal | 1 | 1997 | 555 | 0.010 |
Why?
|
Vitamin E | 1 | 1998 | 869 | 0.010 |
Why?
|
Plethysmography, Impedance | 1 | 1993 | 43 | 0.010 |
Why?
|
Antibody Formation | 1 | 1999 | 1402 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2002 | 6314 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2001 | 2077 | 0.010 |
Why?
|
Glycoproteins | 1 | 2002 | 2263 | 0.010 |
Why?
|
Antigens, Bacterial | 1 | 1999 | 1171 | 0.010 |
Why?
|
Fetal Organ Maturity | 1 | 1993 | 82 | 0.010 |
Why?
|
Phenotype | 1 | 2011 | 16365 | 0.010 |
Why?
|
Autonomic Nerve Block | 1 | 1993 | 72 | 0.010 |
Why?
|
Iopamidol | 1 | 1993 | 191 | 0.010 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 1995 | 419 | 0.010 |
Why?
|
Neoplasms | 1 | 2002 | 21683 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2004 | 3086 | 0.010 |
Why?
|
Rats | 2 | 2004 | 24260 | 0.010 |
Why?
|
Fruit | 1 | 1998 | 1142 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2014 | 25043 | 0.010 |
Why?
|
Vegetables | 1 | 1998 | 1182 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2005 | 9734 | 0.010 |
Why?
|
Lung Volume Measurements | 1 | 1993 | 378 | 0.010 |
Why?
|
Stimulation, Chemical | 1 | 1992 | 326 | 0.010 |
Why?
|
Glycogen | 1 | 1993 | 260 | 0.010 |
Why?
|
Pulmonary Surfactants | 1 | 1993 | 162 | 0.010 |
Why?
|
Neurosurgical Procedures | 1 | 2003 | 2002 | 0.010 |
Why?
|
Mediastinoscopy | 1 | 1992 | 31 | 0.010 |
Why?
|
Japan | 1 | 1996 | 1360 | 0.010 |
Why?
|
Thromboxane B2 | 1 | 1991 | 152 | 0.010 |
Why?
|
Genetic Testing | 1 | 2005 | 3444 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1997 | 2557 | 0.010 |
Why?
|
Gene Amplification | 1 | 1996 | 1063 | 0.010 |
Why?
|
Injections, Epidural | 1 | 1993 | 195 | 0.010 |
Why?
|
Models, Genetic | 1 | 2002 | 3494 | 0.010 |
Why?
|
Spirometry | 1 | 1994 | 864 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2009 | 11483 | 0.010 |
Why?
|
Cyclic GMP | 1 | 1993 | 409 | 0.010 |
Why?
|
Protamines | 1 | 1991 | 106 | 0.010 |
Why?
|
Phosphatidylcholines | 1 | 1993 | 411 | 0.010 |
Why?
|
Palliative Care | 1 | 2006 | 3493 | 0.010 |
Why?
|
Neurons, Afferent | 1 | 1993 | 506 | 0.010 |
Why?
|
Hospital Costs | 1 | 1997 | 985 | 0.010 |
Why?
|
False Negative Reactions | 1 | 1992 | 588 | 0.010 |
Why?
|
Patient Selection | 1 | 2003 | 4215 | 0.010 |
Why?
|
Energy Intake | 1 | 1998 | 2148 | 0.010 |
Why?
|
Cell Lineage | 1 | 1999 | 2504 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 1992 | 11727 | 0.010 |
Why?
|
Cell Nucleus | 1 | 1999 | 2969 | 0.010 |
Why?
|
Dietary Fats | 1 | 1998 | 2017 | 0.010 |
Why?
|
Blood Pressure | 2 | 1999 | 8554 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 1992 | 1420 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2004 | 12026 | 0.010 |
Why?
|
Pain | 1 | 2005 | 4986 | 0.010 |
Why?
|
Random Allocation | 1 | 1994 | 2429 | 0.010 |
Why?
|
Drug Tolerance | 1 | 1991 | 376 | 0.010 |
Why?
|
Muscles | 1 | 1994 | 1614 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2005 | 10481 | 0.010 |
Why?
|
Stomach | 1 | 1994 | 697 | 0.010 |
Why?
|
False Positive Reactions | 1 | 1992 | 981 | 0.010 |
Why?
|
Electrophoresis, Agar Gel | 1 | 1988 | 212 | 0.010 |
Why?
|
Electric Stimulation | 1 | 1994 | 1767 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2004 | 6234 | 0.000 |
Why?
|
Organ Size | 1 | 1993 | 2252 | 0.000 |
Why?
|
Pedigree | 1 | 1995 | 4644 | 0.000 |
Why?
|
Kidney | 1 | 2003 | 7186 | 0.000 |
Why?
|
Oxygen | 1 | 1998 | 4189 | 0.000 |
Why?
|
Respiration | 1 | 1993 | 1653 | 0.000 |
Why?
|
Karyotyping | 1 | 1988 | 1243 | 0.000 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1997 | 3760 | 0.000 |
Why?
|
Molecular Weight | 1 | 1988 | 2255 | 0.000 |
Why?
|
Patient Care Team | 1 | 1997 | 2531 | 0.000 |
Why?
|
Homeostasis | 1 | 1997 | 3340 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 2 | 2003 | 35421 | 0.000 |
Why?
|
Heart Transplantation | 1 | 1998 | 3110 | 0.000 |
Why?
|
Heparin | 1 | 1991 | 1637 | 0.000 |
Why?
|
Pregnancy | 2 | 1999 | 29144 | 0.000 |
Why?
|
Embolization, Therapeutic | 1 | 1993 | 1392 | 0.000 |
Why?
|
Patient Readmission | 1 | 1997 | 3114 | 0.000 |
Why?
|
Neural Pathways | 1 | 1993 | 2972 | 0.000 |
Why?
|
Adipose Tissue | 1 | 1994 | 3279 | 0.000 |
Why?
|
Echocardiography | 1 | 1995 | 5102 | 0.000 |
Why?
|
Body Weight | 1 | 1993 | 4669 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1993 | 8301 | 0.000 |
Why?
|
Electrocardiography | 1 | 1995 | 6442 | 0.000 |
Why?
|
Exercise | 1 | 1997 | 5615 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1991 | 10943 | 0.000 |
Why?
|